[ET Net News Agency, 27 March 2018] Sihuan Pharmaceutical (00460) said its profit
attributable to owners for the year ended 31 December 2017 dropped 15.2% year-on-year to
Rmb1,449 million.
Basic and diluted earnings per share were Rmb15.3 cents.
Revenue amounted to Rmb2,746 million, a decrease of 13.8% from a year earlier.
Gross profit margin increased from 68.7% for 2016 to 72.4% for 2017, which was mainly
due to streamlined production processes and effective cost control measures resulted from
systematic management in the Group's production units.
The proposed final dividend is Rmb1.3 cents (2016: Rmb3.8 cents with special dividend of
Rmb5.5 cents) per share, payable on or around 20 June. (HL)